300
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Identification of novel potential ricin inhibitors by virtual screening, molecular docking, molecular dynamics and MM-PBSA calculations: a drug repurposing approach

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 5309-5319 | Received 21 Aug 2020, Accepted 23 Dec 2020, Published online: 07 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ming-Tai Hu, Wen-Cong Ma, Jing-Han Wang, Xiao-Qing Jiang, Da-Qing Yang & Jian-Yang Ao. (2023) Mechanistic insights into the allosteric inactivation mechanism of ZAP-70 induced by the hot spot W165C mutation. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-10.
Read now

Articles from other publishers (2)

Tanos C. C. França, Fernanda D. Botelho, Michael L. Drummond & Steven R. LaPlante. (2022) Theoretical Investigation of Repurposed Drugs Potentially Capable of Binding to the Catalytic Site and the Secondary Binding Pocket of Subunit A of Ricin. ACS Omega 7:36, pages 32805-32815.
Crossref
Nidhi Singh, Shi-Qing Mao & Wenjin Li. (2021) Identification of Novel Inhibitors of Type-I Mycobacterium Tuberculosis Fatty Acid Synthase Using Docking-Based Virtual Screening and Molecular Dynamics Simulation. Applied Sciences 11:15, pages 6977.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.